近日,佰泽医疗通过了港交所聆讯,并于6月6日更新了聆讯后招股书;由招银国际担任独家保荐人。佰泽医疗是中国主要从事投资及提供医疗相关服务的肿瘤医疗集团。具体而言,佰泽医疗是“肿瘤全周期医疗服务”领域的服务供应商,筛查、诊断、治疗及康复是其在肿瘤全周期医疗服务体系中提供的核心服务。佰泽医疗专注于开展肿瘤相关医疗服务,包括但不限于对患者开展肿瘤诊断、多种手段的肿瘤治疗、肿瘤康复及临终关怀等,以及对包括...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.